EUVIMEDEUVIMED entdecken
Multizentrische Studie

Real-World 1-Year Outcomes of Treatment-Intensive Neovascular Age-Related Macular Degeneration Switched to Faricimab

Sing Yue Sim, Evangelia Chalkiadaki, Georgios Koutsocheras, Luke Nicholson, Sobha Sivaprasad, Praveen J Patel, Senthil Selvam, Bishwanath Pal, Pearse A Keane, Bhairavi Bhatia, Robin Hamilton, Moorfields Medical Retina Injection Service

Ophthalmology Retina · 2025-01 · 9 (1) · 22-30

DOI: 10.1016/j.oret.2024.07.020 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Ophthalmology Retina, 2025-01. Verfasst von Sing Yue Sim und 11 weiteren Autor:innen. Beteiligte Einrichtung: National Institute for Health and Care Research, Biomedical Research Centre at Moorfields Eye Hospital National Health Service Foundation Trust and U…. Hauptthemen laut MEDLINE: Visual Acuity, Intravitreal Injections, Angiogenesis Inhibitors, Recombinant Fusion Proteins. Die Arbeit wurde bisher 49-mal zitiert (Crossref) und nennt 25 Literaturangaben. Gefördert von: National Institute for Health and Care Research (NIHR) Biomedical Research Centre.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Visual AcuityIntravitreal InjectionsAngiogenesis InhibitorsRecombinant Fusion ProteinsRanibizumabWet Macular DegenerationReceptors, Vascular Endothelial Growth FactorTomography, Optical CoherenceHumansRetrospective StudiesMaleFemaleAgedFollow-Up StudiesTreatment OutcomeTime FactorsDrug SubstitutionAged, 80 and overMacula LuteaVascular Endothelial Growth Factor AFluorescein Angiography

Stichwörter der Autor:innen

Anti-VEGFFaricimabNeovascular age-related macular degenerationReal-world, Retina

Substanzen

Angiogenesis InhibitorsRecombinant Fusion ProteinsRanibizumabReceptors, Vascular Endothelial Growth FactorafliberceptVascular Endothelial Growth Factor A

Autor:innen und Institutionen

  • National Institute for Health and Care Research, Biomedical Research Centre at Moorfields Eye Hospital National Health Service Foundation Trust and University College London Institute of Ophthalmology, London, United Ki…

Förderung

  • National Institute for Health and Care Research (NIHR) Biomedical Research Centre

Zitieren

APA

Sim, S. Y., Chalkiadaki, E., Koutsocheras, G., Nicholson, L., Sivaprasad, S., Patel, P. J., Selvam, S., Pal, B., Keane, P. A., Bhatia, B., Hamilton, R., & Moorfields Medical Retina Injection Service (2025). Real-World 1-Year Outcomes of Treatment-Intensive Neovascular Age-Related Macular Degeneration Switched to Faricimab. Ophthalmology Retina, 9(1), 22-30. https://doi.org/10.1016/j.oret.2024.07.020

Vancouver

Sim SY, Chalkiadaki E, Koutsocheras G, Nicholson L, Sivaprasad S, Patel PJ, et al. Real-World 1-Year Outcomes of Treatment-Intensive Neovascular Age-Related Macular Degeneration Switched to Faricimab. Ophthalmology Retina. 2025;9(1):22-30. doi:10.1016/j.oret.2024.07.020

BibTeX
@article{Sim2025,
  author = {Sim, Sing Yue and Chalkiadaki, Evangelia and Koutsocheras, Georgios and Nicholson, Luke and Sivaprasad, Sobha and Patel, Praveen J and Selvam, Senthil and Pal, Bishwanath and Keane, Pearse A and Bhatia, Bhairavi and Hamilton, Robin and Moorfields Medical Retina Injection Service, Moorfields Medical Retina Injection Service},
  title = {Real-World 1-Year Outcomes of Treatment-Intensive Neovascular Age-Related Macular Degeneration Switched to Faricimab},
  journal = {Ophthalmology Retina},
  year = {2025},
  volume = {9},
  number = {1},
  pages = {22--30},
  doi = {10.1016/j.oret.2024.07.020}
}
Kostenlos starten →